Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yehonatan Weinberger"'
Autor:
Yehonatan Weinberger, Ivan Budnik, Yael Nisgav, Dahlia Palevski, Gil Ben-David, José A. Fernández, Shany Nivinsky Margalit, Sarina Levy-Mendelovich, Gili Kenet, Dov Weinberger, John H. Griffin, Tami Livnat
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 10642 (2023)
3K3A-Activated Protein C (APC) is a recombinant variant of the physiological anticoagulant APC with cytoprotective properties and reduced bleeding risks. We studied the potential use of 3K3A-APC as a multi-target therapeutic option for choroidal neov
Externí odkaz:
https://doaj.org/article/b3454c17de6e43fd9276416c1ee5569d
Autor:
Dahlia Palevski, Gil Ben-David, Yehonatan Weinberger, Rabeei Haj Daood, José A. Fernández, Ivan Budnik, Sarina Levy-Mendelovich, Gili Kenet, Yael Nisgav, Dov Weinberger, John H. Griffin, Tami Livnat
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 22, p 14196 (2022)
3K3A-Activated Protein C (APC) is a recombinant variant of the physiological anticoagulant APC with pleiotropic cytoprotective properties albeit without the bleeding risks. The anti-inflammatory activities of 3K3A-APC were demonstrated in multiple pr
Externí odkaz:
https://doaj.org/article/fadb6be406814f558453008fe350d342
Autor:
Yakov Vega, Assaf Gershoni, Asaf Achiron, Raimo Tuuminen, Yehonatan Weinberger, Eitan Livny, Yoav Nahum, Irit Bahar, Uri Elbaz
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 3, p 542 (2021)
Purpose: To examine the contribution of anterior chamber depth (ACD), lens thickness (LT), and white-to-white (WTW) measurements to intraocular lens (IOL) power calculations using the Barrett Universal II (BUII) formula. Methods: Measurements taken w
Externí odkaz:
https://doaj.org/article/e362d374d06a44cfa5158f2ad630118a
Autor:
Tami Livnat, Yehonatan Weinberger, José A. Fernández, Alaa Bashir, Gil Ben-David, Dahlia Palevski, Sarina Levy-Mendelovich, Gili Kenet, Ivan Budnik, Yael Nisgav, John H. Griffin, Dov Weinberger
Publikováno v:
Biomolecules, Vol 11, Iss 3, p 358 (2021)
The activated protein C (APC) ability to inhibit choroidal neovascularization (CNV) growth and leakage was recently shown in a murine model. A modified APC, 3K3A-APC, was designed to reduce anticoagulant activity while maintaining full cytoprotective
Externí odkaz:
https://doaj.org/article/257408fbd8ea498eaece922f8cc88963
Publikováno v:
RETINAL Cases & Brief Reports. 17:181-185
Autor:
Alon Zahavi, Yehonatan Weinberger, Noa Geffen, Itay Gabbay, Michael Mimouni, Orly Gal-or, Hadas Stiebel-Kalish, Dan D Gaton
Publikováno v:
Seminars in Ophthalmology. :1-5
Autor:
Livnat, Yehonatan Weinberger, Ivan Budnik, Yael Nisgav, Dahlia Palevski, Gil Ben-David, José A. Fernández, Shany Nivinsky Margalit, Sarina Levy-Mendelovich, Gili Kenet, Dov Weinberger, John H. Griffin, Tami
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 10642
3K3A-Activated Protein C (APC) is a recombinant variant of the physiological anticoagulant APC with cytoprotective properties and reduced bleeding risks. We studied the potential use of 3K3A-APC as a multi-target therapeutic option for choroidal neov
Publikováno v:
European Journal of Ophthalmology. 32:2840-2844
Purpose To evaluate the outcomes and complications of scleral buckle surgery alone or combined with pneumatic retinopexy (pneumatic buckle) for the treatment of primary rhegmatogenous retinal detachment. Design Retrospective chart review. Participant
Publikováno v:
European Journal of Ophthalmology. 32:102-107
Background: Dacryocystorhinostomy is used to treat nasolacrimal duct obstruction when conservative measures fail. It may be performed via an external or endoscopic-endonasal approach. The aim of this study was to compare the outcomes of patients with
Autor:
Idan Hecht, Zvia Burgansky-Eliash, Raimo Tuuminen, Idit Maharshak, Nardine Sharef, Yehonatan Weinberger, Asaf Achiron, Asaf Bar, Rabea Kassem
Publikováno v:
Ophthalmic Res
Introduction: We have recently shown that defects in interdigitation and ellipsoid zones (IZ and EZ) can predict response to anti-VEGF therapy in a small group of treatment-naive diabetic macular edema (DME) patients. The aim of the current study is